# Defined Green Tea Catechin Extract in Preventing Liver Cancer in Participants With Cirrhosis

> **NCT03278925** · PHASE1 · ACTIVE_NOT_RECRUITING · sponsor: **National Cancer Institute (NCI)** · enrollment: 14 (actual)

## Conditions studied

- Cirrhosis

## Interventions

- **PROCEDURE:** Biopsy
- **PROCEDURE:** Biospecimen Collection
- **PROCEDURE:** Computed Tomography
- **DRUG:** Defined Green Tea Catechin Extract
- **OTHER:** Laboratory Biomarker Analysis
- **PROCEDURE:** Magnetic Resonance Imaging
- **OTHER:** Pharmacological Study
- **OTHER:** Questionnaire Administration
- **PROCEDURE:** Ultrasound

## Key facts

- **NCT ID:** NCT03278925
- **Lead sponsor:** National Cancer Institute (NCI)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2018-08-09
- **Primary completion:** 2023-06-16
- **Final completion:** 2024-12-31
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2024-08-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03278925

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03278925, "Defined Green Tea Catechin Extract in Preventing Liver Cancer in Participants With Cirrhosis". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT03278925. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*